Search
CVN-424
go.drugbank.com/drugs/DB18958InvestigationalCVN-424 is under investigation in clinical trial NCT06006247 (Early Parkinson's Disease Monotherapy With CVN424).
Chlorophetanol
go.drugbank.com/drugs/DB11368ExperimentalChlorophetanol is an agent known to have antifungal activities.
RO-5028442
go.drugbank.com/drugs/DB12721InvestigationalRO5028442 has been used in trials studying Autistic Disorder.
ACT-451840
go.drugbank.com/drugs/DB13054InvestigationalACT-451840 has been used in trials studying Malaria.
Ferric oxyhydroxide
go.drugbank.com/drugs/DB14695ExperimentalAn antiferromagnetic material; constitutes the core of natural ferritin.
IK-930
go.drugbank.com/drugs/DB18149InvestigationalIK-930 is an oral, paralog-selective TEAD inhibitor.
Ceftiofur
go.drugbank.com/drugs/DB11485ExperimentalVet approvedE. coli strains resistant to ceftiofur have been reported. … Ceftiofur is a third generation cephalosporin antibiotic, first described in 1987, and now used in veterinary medicine.
Zilovertamab vedotin
go.drugbank.com/drugs/DB18457Investigationalmc-vc-PAB), and a monomethyl auristatin E (MMAE) cytotoxin. … Zilovertamab vedotin is an Antibody-drug conjugate (ADC) comprising an anti-ROR1 monoclonal antibody (UC-961), a proteolytically cleavable maleimidocaproyl-valine-citrulline-para-aminobenzoate linker (
Pilavapadin
go.drugbank.com/drugs/DB21552InvestigationalPilavapadin is under investigation in clinical trial NCT06203002 (A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)).